SWOG clinical trial number
SWOG-7807
Cis-Diamminedichloroplatinum (II) in the Treatment of Refractory Epidermoid Carcinomas of the Lung
Closed
Abbreviated Title
Cis-Diamminedichloroplatinum (II) in the Treatment of Refractory Epidermoid Carcinomas of the Lung
Activated
03/29/1978
Closed
04/14/1980
Publication Information Expand/Collapse
1983
Evaluation of single-agent Cisplatin in the management of non-small cell carcinoma of the lung. A Southwest Oncology Group study.
1981
Cis-platinum (CACP) toxicity. An analysis based on 3 Southwest Oncology Group studies.
Cis-platinum (CACP) toxicity. An analysis based on 3 Southwest Oncology Group studies.
Cis-platinum (CACP) toxicity. An analysis based on 3 Southwest Oncology Group studies.
1980
Effects of the two-dose Southwest Oncology Group Cis-platinum (CACP) program in non-oat cell lung cancer.